baber/WOPTO huggingface dataset:
Patent ES-551203-A0 (ES)
IPC: C12P17/06
Filed: 1986-01-24
Abstract: 1. A process for the preparation of forskolin derivatives, which comprises a particular microorganism being allowed to act on a particular forskolin derivative as substrate in a nutrient medium in a customary manner and, after completion of the fermentation, the compound which has formed being isolated from the culture broth and the mycelium by extraction with an organic solvent and subsequent chromatography and/or crystallization, where a) with the compound of the formula III  see diagramm : EP0189801,P16,F1  as substrate and using the strain H/134 (DSM 3205), there is obtained the compound of the formula IV  see diagramm : EP0189801,P16,F2  b) with the compound of the formula IV as substrate and using the strain FF/406 (DSM 3211), there is obtained the compound of the formula V  see diagramm : EP0189801,P16,F3  in which Ac denotes the radical CH3 CO-, c) with the compound of the formula VI  see diagramm : EP0189801,P16,F4  in which Ac denotes the radical CH3 CO-, as substrate and c1 ) using the strain FF/172 (DSM 3208), there is obtained the compound of the formula VII  see diagramm : EP0189801,P17,F5  or c2 ) using the strain FF/101 (DSM 3207), there is obtained the compound of the formula VIII  see diagramm : EP0189801,P17,F6  in which Ac denotes the radical CH3 CO-, or c3 ) using the strain H/134 (DSM 3205), there is obtained the compound of the formula IX  see diagramm : EP0189801,P17,F7  or c4 ) using the strain FF/101 (DSM 3207), there is obtained the compound of the formula X  see diagramm : EP0189801,P17,F8  in which Ac denotes the radical CH3 CO-, or c5 ) using the strain H/134 (DSM 3205), there is obtained the compound of the formula XI  see diagramm : EP0189801,P18,F9  in which Ac denotes the radical CH3 CO-, or c6 ) using the strain FF/173 (DSM 329) or H/1 (DSM 3202), there is obtained the compound of the formula XII  see diagramm : EP0189801,P18,F10  in which Ac denotes the radical CH3 CO-, or c7 ) using the strain FF/383 (DSM 3210), there is obtained the compound of the formula XIII  see diagramm : EP0189801,P18,F11 or C8 ) using the strain FF/695 (DSM 3212), there is obtained the compound of the formula XIV  see diagramm : EP0189801,P18,F12  in which Ac denotes the radial CH3 CO-, or c9 ) using the strain FF/93 (DSM 3206) or FF/172 (DSM 3208), there is obtained the compound of the formula XV  see diagramm : EP0189801,P19,F13  or c10 ) using the strain H/3 (DSM 3203) or H/19 (DSM 3204) or Y-82 52 904 (DSM 3213), there is obtained the compound of the formula XVI  see diagramm : EP0189801,P19,F14  or c11 ) using the strain H/1 (DSM 3202), there is obtained the compound of the formula XVII  see diagramm : EP0189801,P19,F15  in which Ac denotes the radical CH3 CO-.
Patent FI-822965-A0 (FI)
Inventor: PLIEFKE ENGELBERT
IPC: G03F7/26
Filed: 1982-08-26
Abstract: In the development of exposed light-sensitive reproduction layers using an aqueous electrolyte developer the parts of the layer corresponding to the non-image areas are removed by electrochemical treatment. An electrolyte is used which has a pH in the range from 2.0 to 10.0 and contains at least one salt in a concentration of 0.1 weight percent up to the saturation limit of the solution for the particular salt. The electrolyte may also contain 0.1 to 5 weight percent surfactant.
Patent FI-844238-A0 (FI)
Inventor: RILEY DEREK CHARLES
IPC: C07J71/00
Filed: 1984-10-29
Abstract: The present invention relates to a method of preparing steroid compounds in a form having a particle size within a desired and specific range. 
<??>The compounds prepared by the method of the invention are those having a basic ring structure of the general formula: 
<CHEM>
 wherein X represents the remainder of a heterocyclic ring, in particular a 5-membered ring having at least 2 heteroatoms, and the method comprises dissolving the compound in an organic solvent, precipitating the compound by mixing a non-solvent for the compound with the said solution, and controlling the mixing conditions to produce a precipitate having the desired reduced particle size.
Patent FI-852873-A0 (FI)
Inventor: NATTRASS FRANK
IPC: B65D88/16
Filed: 1985-07-24
Abstract: A flexible bulk container has a side wall structure 1 formed from a length of tubular woven fabric comprising a base fabric and a plurality of parallel reinforcing bands such as 2 to 5 integrally woven with the base fabric and extending parallel to the tube axis. A bottom 26 is stitched to the side wall structure at one end of the fabric length and a top wall structure 24 may be secured at the other end of the fabric length. The container has a plurality of lifting loops 20 to 23 at the top end of the fabric length, each lifting loop being formed by cutting back a portion of the base fabric alongside each of two adjacent reinforcing bands (e.g. 3 and 4) to leave- parts of the bands projecting from the base fabric, and securing together the free ends of the projecting parts to form the loop (e.g. 20). One of the projecting parts may be twisted through 180° before the free ends are joined together.
Patent FI-854097-A0 (FI)
Inventor: LEMAIRE JEANNINE
IPC: A47C1/034
Filed: 1985-10-21
Abstract: Convertible chair of the kind consisting in a seat, a back and a foot-rest, each mobile with respect to the other and all together, characterized in that in a fixed base that assures the stability of the chair on the ground, is lodged a sole jack and all of the connecting rods that control the tilting of the seat itself, of its back and of the foot-rest, and the operation of the piston of this sole jack controls a main lever that sequentially exerts its action to tilt the back, then, either separately or simultaneously, to tilt the seat, and then, either separately or simultaneously, to tilt the foot-rest; this moving of the main lever itself results from direct contact or through the intermediary of secondary levers, with stops activating the moving of levers, each interdependent on the respective rotating axles of the three parts of the chair, in one direction or the other.
Patent FI-862650-A0 (FI)
Inventor: GRELL WOLFGANG
IPC: A61K31/395
Filed: 1986-06-23
Abstract: 1. Two new solid forms of 2-ethoxy-4-[N-(1-(2-piperidino- phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, the form designated (B) being characterised by the melting point of 140-142 degrees C and by the IR(KBr) spectrum according to Figure B' and the form designated (C) being characterised by a melting point of 75-85 degrees C and by the IR(KBr) spectrum according to Figure C'.
Patent FI-872229-A0 (FI)
Inventor: SPYCHER PIERRE
IPC: G08B29/04
Filed: 1987-05-21
Abstract: The security device against theft of objects, e.g. paintings and containers of valuables, has a stationarily mounted housing (1) for receiving protective tube contacts (3 to 9) and a permanent magnet (2). A plate (10) is attached to the housing (1) so as to be rotatable on one side. Arranged on said plate are several permanent magnets (11 to 13), the plate (10) being ejected by the permanent magnets (2, 11) in such a way that it contacts the object (14). Two protective tube contacts (7, 8) are arranged in the housing (1) and two permanent magnets (12, 13) are arranged on the plate (10) in such a way that an alarm is triggered if the object (14) is situated at a certain minimum or maximum distance from the housing (1). The device is flat, compact, light and has a high degree of operational reliability and security against sabotage. No constructional elements of the device are mounted on the object, with the result that the object is not altered or disfigured. <IMAGE>
Patent FI-874261-A0 (FI)
Inventor: ANDERSSON KJELL
IPC: A47F5/13
Filed: 1987-09-29
Abstract: A distribution system comprising box-shaped transport containers (5) provided with bottom (18) and walls (20) and a truck (1) provided with wheels which has swinging side walls (3 and 4) in hinged connection with a vertical end wall (2). The side walls (3 and 4) have supporting elements placed oppositely in pairs, e.g. horizontal L-shaped rails (22) which are positively engageable with members formed on the transport trays (5), e.g.channels (21) incorporated at the bottom (18) of the transport trays, to facilitate in co-operation with these members loading by insertion of the transport trays (5) and securing of the side walls (3 and4) when these are in their active position.
Patent FI-881293-A0 (FI)
Inventor: MUSCALA JAMES A
IPC: B65D41/54
Filed: 1988-03-18
Abstract: A seal for a bottle and cap assembly. The seal is formed from a heat shrink sheet (12) which is adhesively coated on one side. A pull tab (42) is formed by a pair of cuts in one edge of the sheet forming the seal and a tear strip (54) is adhesively secured to the back of the sheet in registration with the pull tab. After being adhesively secured to a bottle and cap assembly, the sheet is heat shrunk to conform to the contour of the bottle (64) and to provide a flange (70) over the bottle cap (62). In one embodiment the pull tab is in registration with the area of joinder between the cap and the bottle and in another, the sheet is devoid of adhesive in an area extending from the pull tab and bridging the joinder between the cap and bottle. In either case, pulling of the pull tab separates the sheet into a first piece adhered to the cap and a second piece adhered to the bottle allowing for the only possible access to the bottle without evidence of tampering showing in the sheet.
Patent FI-911647-A0 (FI)
Inventor: BASTIOLI CATIA
IPC: C08L23/26
Filed: 1991-04-05
Abstract: PCT No. PCT/EP90/01253 Sec. 371 Date Mar. 27, 1991 Sec. 102(e) Date Mar. 27, 1991 PCT Filed Aug. 1, 1990 PCT Pub. No. WO91/02024 PCT Pub. Date Feb. 21, 1991.Polymer compositions useful for the production of articles of biodegradable plastics material with improved biodegradability include destructed starch and a polymer selected from the group consisting of ethylene-vinyl alcohol, polyvinyl alcohol and mixtures thereof wherein at least a portion of the said polymer is modified by the substitution of from 0.1 to 5 molar % of the functional alcohol groups in the polymer chain by X groups in which X is an oxo or an alkyl carbonyl group in which the alkyl group contains from 1 to 4 carbon atoms.
Patent FI-913403-A0 (FI)
Inventor: BRAENNSTROEM ROINE
IPC: F23J1/02
Filed: 1991-07-15
Abstract: PCT No. PCT/SE90/00024 Sec. 371 Date Jul. 16, 1991 Sec. 102(e) Date Jul. 16, 1991 PCT Filed Jan. 12, 1990 PCT Pub. No. WO90/08085 PCT Pub. Date Jul. 26, 1990.A pneumatic transport system for transferring particulate material from a first pressurized container to a second container which is under a lower pressure, while successively reducing the pressure, comprising a number of parallel tubes (36), arranged in series, said tubes being joined together at their ends by means of transfer chambers (38) for transferring a gas/material stream from an upstream tube (36) to a downstream tube (36). The transfer chamber (38) are formed with tubular inlets and outlets (52, 56) opening out into a space (54) where a gas/material stream is transferred from the inlet (52) to the outlet (56). Between the inlet (52) and the outlet (56) there is a double-bent unsymmetrical surface, bulging towards the space (54), which conforms to the wall surfaces of the inlet (52) and the outlet (56).
Patent FI-913906-A0 (FI)
Inventor: KOHNERT ULRICH
IPC: A61K47/12
Filed: 1991-08-19
Abstract: The invention relates to a pharmaceutical preparation of a non-glycosylized t-PA derivative, K1K2P pro, with an enzymatic activity of at least 0.4 MU/ml and a pH of 4.5 to 6, containing citrate and at least one compound from the following group: a) ascorbic acid, b) EDTA, c) amino compounds of formula R?1R?2N -R - X, where X = SO3?H, CH(NH2?)-CO2?H, CO2?H, H, NH2? or OH, R = C1?-C9? alkylene, C3?-C6? cycloalkylene or benzylidene and R?1 and R?2, independently of each other, are H or C1?-C3? alkyl, d) guianidinobutyric acid, e) dimethylbiguanide, f) arginine, g) glucosamine, fructose, h) pyrimidine nucleosides and pyrimidine nucleotides, i) carboxylic acids substituted with one or more hydroxyl, keto and/or further carboxyl groups. The invention also relates to a drug containing the t-PA derivative K1K2P pro as the active ingredient and a process for producing it.
Patent FI-915195-A0 (FI)
Inventor: TSAI TED YUAN
IPC: D21C9/14
Filed: 1991-11-04
Abstract: A method of enhancing the quality of a pulp which has been subjected to a chlorine-based bleaching agent, by subjecting the chlorinated pulp to ozonation prior to an extraction stage in the bleaching sequence. The improved pulp of the present invention includes reduction of total organically bound chlorine residues in the wood pulp and adsorbed organic halides (AOX) in the effluent, and has good brightness and viscosity. The advantages of the present invention may be accomplished by means of a bleaching sequence that employs as few as four stages, namely DZED with attendant relatively lower capital investment than heretofore possible.
Patent FI-940148-A0 (FI)
Inventor: KESKITALO ILKKA
IPC: H04B7/005
Filed: 1994-01-12
Abstract: PCT No. PCT/FI95/00007 Sec. 371 Date Nov. 3, 1995 Sec. 102(e) Date Nov. 3, 1995 PCT Filed Jan. 11, 1995 PCT Pub. No. WO95/19664 PCT Pub. Date Jul. 20, 1995The invention relates to a data transmission method in a CDMA cellular radio system, which comprises in each cell at least one base station (10) communicating with mobile stations (11, 12) within its coverage area and in which system the base station adjusts the transmitting power of the mobile stations within its area by means of power control massages. To enable coherent detection at the base station, according to the method the transmission on the traffic channel is performed both in the transmission direction from the mobile station to the base station and from the base station to the mobile station by using a similar frame structure. When the base station transmits a power control message to the mobile station by using bits of the frame structure of the traffic channel, the mobile station transmits a predetermined bit pattern to the base station in the corresponding bits of the other transmission direction of the traffic channel.
Patent FI-962301-A0 (FI)
Inventor: KOHL BERNHARD
IPC: C07D405/14
Filed: 1996-05-31
Abstract: PCT No. PCT/EP94/03911 Sec. 371 Date May 31, 1996 Sec. 102(e) Date May 31, 1996 PCT Filed Nov. 26, 1994 PCT Pub. No. WO95/15324 PCT Pub. Date Jun. 8, 1995Compounds of formula I    <IMAGE>  (I)  wherein R1, R2, R3, R4, R5, R6, X, n and A have the meanings as given in the description, can be used for combatting Helicobacter bacteria.
Patent FI-964483-A0 (FI)
Inventor: SCHUBERT KLAUS
IPC: B01F5/04
Filed: 1996-11-07
Abstract: In the proposed reaction process, at least two educts (A, B) are divided by their respective assemblies of microchannels (1a, 1b) into spatially separated fluid filaments. These fluid filaments then enter a common mixing and reaction chamber (4). It is essential that the fluid filaments of the two educts (A, B) are allowed to enter the mixing/reaction chamber (4) as free jets (6a, 6b), each free jet (6a) of an educt (A) being led into the mixing/reaction chamber (4) immediately adjacent to a free jet (6b) of a different educt (B). Adjacent free jets then mix by diffusion and/or turbulence. This system significantly accelerates the mixing process by comparison with conventional reactors, and, with rapid chemical reactions, largely prevents the formation of unwanted by-products and secondary products.
Patent FI-971420-A0 (FI)
Inventor: AUKERMAN SHARON LEA
IPC: A61P27/02
Filed: 1997-04-04
Abstract: A method and pharmaceutical compositions are described for the use of keratinocyte growth factor to treat diabetes in mammals.
Patent FI-972104-A0 (FI)
Inventor: JENSEN JENS ANDERS
IPC: A23C3/037
Filed: 1997-05-16
Abstract: PCT No. PCT/DK95/00453 Sec. 371 Date May 19, 1997 Sec. 102(e) Date May 19, 1997 PCT Filed Nov. 14, 1995 PCT Pub. No. WO96/15677 PCT Pub. Date May 30, 1996A plant for continuously sterilizing fluids, such as milk and cream comprises a sterilizing device (2) in which the fluid is sterilized while steam is fed thereto, and a vacuum chamber (1) for removal of the water from the fluid and from which the fluid is extracted by means of a pump (8). The vacuum chamber (1) is accommodated before the sterilizing device (2) when seen in the flow direction of the fluid, said vacuum chamber (1) being connection to said sterilizing device (2) through a first heat exchanger (11) for heating the fluid before it enters said sterilizing device (2).
Patent IL-64902-A0 (IL)
Title: Carbacyclin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07C69/732
Filed: 1982-01-31
Abstract: 1. Claims for the contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Carbacyclin derivatives of the general formula I  see diagramm : EP0057660,P15,F5  wherein R1 is the group OR2 , where R2 is hydrogen or alkyl of 1-4 carbon atoms, or the group NHR3 , where R3 is acetyl, methanesulfonyl or hydrogen, W is a hydroxymethylene group or a  see diagramm : EP0057660,P15,F6  group, in which the OH is in the alpha- or beta-configuration, D is a straight or branched chain alkylene group of 1-5 carbon atoms, R4 is alkyl of 1-7 carbon atoms, and when R2 is hydrogen, salts of these compounds with physiologically acceptable bases. 1. Claim for the contracting State : AT Process for the preparation of the carbacyclin derivatives of the general formula I  see diagramm : EP0057660,P17,F1  wherein R1 is the group OR2 , where R2 is hydrogen or alkyl of 1-4 carbon atoms, or the group NHR3 , where R3 is acetyl, methanesulfonyl or hydrogen, W is a hydroxymethylene group or a  see diagramm : EP0057660,P17,F2 group, in which the OH is in the alpha- or beta-configuration, D is a straight or branched chain alkylene group of 1-5 carbon atoms, R4 is alkyl of 1-7 carbon atoms, and when R2 is hydrogen, salts of these compounds with physiologically acceptable bases, characterised in that a double bond is introduced in known manner in the 2-position into a compound of general formula II  see diagramm : EP0057660,P17,F3  by reacting it with a lithium alkylamine of general formula III  see diagramm : EP0057660,P18,F1  wherein R8 and R9 are alkyl of 1-10 carbon atoms, cycloalkyl of 3-6 carbon atoms or a trialkylsilyl group in which the alkyl is of 1-4 carbon atoms, treating it with a phenyl compound of general formula IV  see diagramm : EP0057660,P18,F2  in which R10 is the group  see diagramm : EP0057660,P18,F3   see diagramm : EP0057660,P18,F4  or -Se-Br and oxidising it, and then optionally, and in an arbitrary sequence separating the isomers, and/or freeing protected hydroxy groups, and/or esterifying or etherifying free hydroxy groups, and/or esterifying a free carboxyl group and/or saponifying an esterified carboxyl group or converting a carboxyl group into a -CONHR3 group or into a salt with a physiologically acceptable base.
Patent IL-75725-A0 (IL)
Title: Lymphokine production and purification
IPC: C12P21/00
Filed: 1985-07-04
Abstract: A method for preparing and isolating a transformation vector containing CSF/cDNA is described. The method comprises:  preparing RNA from a cell that produces CSF;  preparing polyadenylated messenger RNA from said RNA;  preparing single stranded cDNA from said messenger RNA;  converting the single stranded cDNA to double stranded cDNA; inserting the double stranded cDNA into transformation vectors and transforming bacteria with said vector to form colonies; picking pools of 200 to 500 colonies each and isolating plasmid DNA from each pool; transfecting the plasmid DNA into suitable host cells for expressing CSF protein; culturing the transfected cells and assaying the supernatant for CSF activity; and selecting CSF positive pools and screening the colonies used to make the pool to identify a colony having CSF activity. Also described are a cDNA coding for a protein having CSF activity (i.e. CSF/cDNA), a microorganism or cell line transformed with a recombinant vector containing such CSF/cDNA, and a method for producing CSF protein by expressing said CSF/cDNA by culturing a microorganism or cell line. The invention also provides a method of purifying the CSF proteins and the purified proteins so produced.
Patent IL-90763-A0 (IL)
Title: Applicator for liquid eye preparations
IPC: A61F9/00
Filed: 1989-06-27
Abstract: An applicator for liquid ophthalmic solution is provided which has a laterally protruding spout (2) and a resiliently flexible wall portion. Application of ophthalmic solution to the eye is performed by placing the tip of the spout (2) on the lower eyelid and by applying pressure to the flexible wall portion, whereupon the ophthalmic solution flows directly into the eye.
Patent AU-PN193095-A0 (AU)
Title: Potassium ion channel blockers
IPC: C07D521/00
Filed: 1995-03-24
Abstract: PCT No. PCT/AU96/00151 Sec. 371 Date Jan. 23, 1998 Sec. 102(e) Date Jan. 23, 1998 PCT Filed Mar. 21, 1996 PCT Pub. No. WO96/30341 PCT Pub. Date Oct. 3, 1996The invention provides novel sulphonylurea, sulphonylthiourea and sulphonylguanidine compounds which have the ability to block potassium ion channels regulated by intracellular concentrations of ATP. Methods of synthesis, pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes, cardiac arrhythmias, ischaemic and hypoxic cardiovascular incidents, and cancers are also claimed.
Patent AU-PS192602-A0 (AU)
Title: Nasal mask
IPC: A62B18/02
Filed: 2002-04-23
Abstract: A respiratory mask assembly (10) for delivering breathable gas to a patient includes a frame (20) having a main, body (20a) and a side frame member (20b) provided on each lateral side of the main body. Each side frame member includes an integrally formed first connector portion. A headgear assembly (80) is removably attachable to the frame (20). The headgear assembly has a second connector portion (82) arranged to be removably coupled with the first connector portion provided on the frame. The second connector portion is manually movable to a releasing position to detach the headgear assembly from the frame. The headgear assembly is rotationally adjustable with respect to the frame.
Patent FI-20030732-A0 (FI)
Inventor: MIETTINEN ERKKI
IPC: H02H3/253
Filed: 2003-05-15
Abstract: This publication discloses a phase failure detector ( 1 ) for a multi-phase electricity supply network. The phase failure detector includes one detector circuit ( 3 ) for each phase ( 2 ), which has a first connection point ( 4 ) for connecting to the phase ( 2 ) being monitored and a second connection point ( 5 ), which is connected to a common connection point ( 9 ) of the detectors circuits. The detector circuits ( 3 ) in turn include capacitive voltage divider elements ( 6 ), which are located between the first ( 4 ) and the second ( 5 ) connection point and with the aid of which reduced voltage is divided and fed to a trigger and detector circuit ( 8 ), which is arranged to produce a detection pulse when the reduced voltage reaches a trigger value.
Patent IL-104006-A0 (IL)
Title: Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
IPC: C07D405/06
Filed: 1992-12-07
Abstract: Azaheterocyclylmethylchromans are prepared by reaction of appropriate methylchromans with appropriate azaheterocycles, optionally with subsequent variation of the substituents. The azaheterocyclymethylchromans can be employed as active compounds in medicaments, in particular for the treatment of disorders of the central nervous system.